Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2025 08:30 ET | Source: Vivos Inc.

Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA

Kennewick, WA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Following the 30-day review period, the FDA declined approval of the Radiogel® IDE submission. We are now focused on...
June 21, 2023 08:01 ET | Source: Ocean Biomedical, Inc.

Ocean Biomedical (NASDAQ: OCEA) Announces Share Price Target Increase to $17.63 by Fundamental Research Corp. on Positive Results from Independent Study Showing Glioblastoma Tumor Suppression, Received Patents, and Recent Financing

Providence, RI, June 21, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: “OCEA”), a next-generation biopharma company working to accelerate the development and commercialization of...
April 12, 2022 09:15 ET | Source: Clinical Trial Guide

Clinical Trial Guide Launches online to help patients and caregivers navigate the clinical trial process

This new resource at clinicaltrialguide.com seeks to transform the way patients and their caregivers understand and navigate the often overly complicated process of clinical trial...
March 24, 2020 09:00 ET | Source: Akers Biosciences Inc.

Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech

Established D-Crypt™ platform will be used to develop a proof-of-concept targeting three of the top five viral vaccine protein candidates for CoronavirusCurrent Regulatory environment could lead to...